Drug-Induced Hyperkinetic Movement Disorders

作者: Pierre J. Blanchet

DOI: 10.1007/978-1-60327-120-2_8

关键词: Intensive care medicineTardive dyskinesiaDrugAccidentalAntipsychotic drugNeuroleptic malignant syndromeDeep brain stimulationMedicineMovement disorders

摘要: Given their prevalence, the wealth of potentially offending drug classes, and potential for reversibility, all hyperkinetic movement disorders should at first be considered iatrogenic until proven otherwise. A high index suspicion is only way to lead clinician consult as many sources information needed regarding past or current, accidental therapeutic, exposure, in order identify eliminate if possible triggering factor. Drug-induced display multiple faces which considerably enriched phenomenology (Table 8.1). They may arise following acute, subacute, chronic occur a remitting, relapsing, persisting fashion, expressed various body parts, give rise wide array manifestations. One feature liability cause complex pictures with coexistence two more [1]. Such presentations hinder correct diagnosis some time.

参考文章(238)
ANTON J. M. LOONEN, HETTY A. VERWEY, PETER R. ROELS, LAURENS P. VAN BAVEL, CEES H. DOORSCHOT, Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology. ,vol. 12, pp. 39- 42 ,(1992) , 10.1097/00001573-199202000-00007
Joseph A. Mauriello, Paul Carbonaro, Shamina Dhillon, Tina Leone, Mark Franklin, Drug-associated facial dyskinesias--a study of 238 patients. Journal of Neuro-ophthalmology. ,vol. 18, pp. 153- 157 ,(1998) , 10.1097/00041327-199806000-00016
Takeshi Terao, Michi Terao, Reiji Yoshimura, Kazuhiko Abe, Restless legs syndrome induced by lithium. Biological Psychiatry. ,vol. 30, pp. 1167- 1170 ,(1991) , 10.1016/0006-3223(91)90185-O
Mario Rodrigues Louzã, Debora Pastore Bassitt, None, Maintenance treatment of severe tardive dyskinesia with clozapine: 5 years' follow-up. Journal of Clinical Psychopharmacology. ,vol. 25, pp. 180- 182 ,(2005) , 10.1097/01.JCP.0000155823.59585.88
M. R. Luquin, O. Scipioni, J. Vaamonde, O. Gershanik, Jos� A. Obeso, Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Movement Disorders. ,vol. 7, pp. 117- 124 ,(1992) , 10.1002/MDS.870070204
Alisdair McNeill, Chorea induced by low-dose trazodone. European Neurology. ,vol. 55, pp. 101- 102 ,(2006) , 10.1159/000092784
N. Vanacore, G. Suzzareddu, M. Maggini, A. Casula, P. Capelli, R. Raschetti, Pisa syndrome in a cohort of Alzheimer's disease patients. Acta Neurologica Scandinavica. ,vol. 111, pp. 199- 201 ,(2005) , 10.1111/J.1600-0404.2005.00388.X
Stéphane Thobois, Jing Xie, Helena Mollion, Isabelle Benatru, Emmanuel Broussolle, Adrafinil-induced orofacial dyskinesia. Movement Disorders. ,vol. 19, pp. 965- 966 ,(2004) , 10.1002/MDS.20154
Filip Bouckaert, Griet Herman, Joseph Peuskens, Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine. International Journal of Geriatric Psychiatry. ,vol. 20, pp. 287- 288 ,(2005) , 10.1002/GPS.1285
Isabelle Éthier, Hiroyuki Kagechika, Koichi Shudo, Claude Rouillard, Daniel Lévesque, Docosahexaenoic acid reduces haloperidol-induced dyskinesias in mice: involvement of Nur77 and retinoid receptors. Biological Psychiatry. ,vol. 56, pp. 522- 526 ,(2004) , 10.1016/J.BIOPSYCH.2004.06.036